Schizophrenia signs detectable in newborn blood, study finds

Researchers have identified genetic markers in newborns' blood that predict schizophrenia risk in adulthood, opening a potential screening pathway for early intervention. The findings could reshape psychiatric care by enabling preventive treatment decades before symptoms emerge, with significant implications for mental health policy and pharmaceutical development.

Originaltitel: Genes implicated by a methylome-wide schizophrenia study in neonatal blood show differential expression in adult brain samples